C4 Therapeutics ( ($CCCC) ) has shared an update. On October 16, 2025, C4 Therapeutics announced an underwritten offering of common stock and ...

Medicines announced a proposed public offering of its common stock and, in lieu of common stock to certain investors, ...

Concurrent with the proposed public offering, Lexeo intends to sell shares of its common stock, and, in lieu of common stock, pre-funded warrants to purchase shares of its common stock, to Balyasny ...

Canaccord Genuity is acting as the sole bookrunner for the offering. Roth Capital Partners is acting as co-manager for the offering.

Dragonfly Energy shares were 30% lower, at $1.38, after the company priced an underwritten public offering of 36 million shares at $1.35 a share and prefunded warrants to buy up to 5 million shares at ...

NEW YORK CITY, NEW YORK / ACCESS Newswire / October 14, 2025 / On October 7, 2025, Humacyte, Inc. (Nasdaq:HUMA), a commercial-stage biotechnology platform company developing universally implantable, ...

Envoy Medical (NASDAQ:COCH) has announced it has entered into definitive agreements for a new capital raise, for issuance and sell an aggregate of 3,007,524 shares of Class A common stock in a ...

EyePoint Pharmaceuticals (EYPT) has announced the pricing of a significant underwritten public offering expected to generate approximately $150 million in gross proceeds. The capital raise is primaril ...

SAN JOSE, Calif., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Energous Corporation d/b/a Energous Wireless Power Solutions (Nasdaq: WATT) (“Energous” or the “Company”), a pioneer in scalable, over-the-air (OTA ...